This is informed speculation, not proven protocol
Conclusion: L-carnitine or acetyl-L-carnitine as a supplementary nutrient could prevent or improve the clinical picture of MASLD in people at risk of dioxin toxicity
Metabolic support: Assist in reducing body fat and improving overall metabolism
The momentum behind GLP-1 is undeniable
One example is retatrutide, a triple agonist targeting GLP-1, GIP, and glucagon receptors, which demonstrated statistically significant weight loss (22.8-24.2%) and metabolic improvements in systolic and diastolic blood pressure and levels of glycated hemoglobin, fasting glucose, insulin, and lipids in a 48-week phase 2 trial, highlighting its potential for future obesity management
Likely mechanisms include rapid weight loss, insulin/insulin-like growth factor 1 signaling, androgen changes, and direct follicular effects